Evonik Industries (FRA:EVK) has been assigned a €34.00 ($39.53) price target by investment analysts at Barclays in a note issued to investors on Tuesday. The brokerage currently has a “buy” rating on the stock. Barclays’ price objective would suggest a potential upside of 25.55% from the stock’s previous close.
Several other research firms also recently commented on EVK. Sanford C. Bernstein set a €35.00 ($40.70) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Monday, September 24th. UBS Group set a €29.00 ($33.72) price objective on Evonik Industries and gave the stock a “sell” rating in a research note on Monday, September 24th. Berenberg Bank set a €38.00 ($44.19) target price on Evonik Industries and gave the company a “buy” rating in a research note on Friday, August 3rd. Independent Research set a €34.00 ($39.53) target price on Evonik Industries and gave the company a “neutral” rating in a research note on Tuesday, August 7th. Finally, Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a “buy” rating in a research note on Friday, August 3rd. Five investment analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the stock. Evonik Industries presently has a consensus rating of “Hold” and a consensus price target of €35.14 ($40.86).
FRA EVK opened at €27.08 ($31.49) on Tuesday. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: What does cost of debt say about a company’s financial health?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.